Chemical Structure : SCO-267
CAS No.: 1656261-09-4
货号: PC-72109Not For Human Use, Lab Use Only.
SCO-267 (SCO267) is a potent, orally available GPR40/FFAR1 full agonist with EC50 of 12 nM (hGPR40).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥2580 | In stock | |
10 mg | ¥3980 | In stock | |
25 mg | ¥5980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SCO-267 (SCO267) is a potent, orally available GPR40/FFAR1 full agonist with EC50 of 12 nM (hGPR40).
SCO-267 activated Gq signaling in both high- and low-FFAR1-expressing CHO cells, increased insulin, glucagon, GLP-1, glucose-dependent insulinotropic peptide, and peptide YY (PYY) secretions under nonfasting conditions in rats, induced GLP-1 secretion, food intake inhibition, and body weight reduction in mice.
SCO-267 effectively stimulated insulin secretion and GLP-1 release and ameliorated glucose tolerance in diabetic rats via GPR40 full agonism.
分子量 | 614.787 | |
分子式 | C36H46N4O5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-3-Cyclopropyl-3-(2-((1-(5-methoxy-2-((6-methylpyridin-2-yl)(neopentyl)carbamoyl)phenyl)piperidin-4-yl)methoxy)pyridin-4-yl)propanoic acid |
1. Hikaru Ueno, et al. J Pharmacol Exp Ther. 2019 Aug;370(2):172-181.
2. Hideki Furukawa, et al. J Med Chem. 2020 Sep 24;63(18):10352-10379.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright